Project Grant R03DK143921
- This federal Project Grant award for $390,000 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award aims to study the impact of step therapy utilization management strategies on access to care for patients with overactive bladder (OAB), as well as evaluate alternative patient-centered treatment approaches. Key objectives include using electronic health...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1,192,362 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Averto Medical Inc., a medical device manufacturer in Fremont, California. The grant supports a safety and efficacy clinical trial of Averto's COLOSEAL ICD System, a minimally invasive medical device designed as an alternative to temporary ostomies for the surgical treatment of...
- This Project Grant award of $1,429,924 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) is supporting the development of a novel, shape-changing sling for the treatment of stress urinary incontinence (SUI) in women. The goal is to create a minimally-invasive sling that can both support the urethra to achieve continence and be activated to reduce pressure on the urethra to enable complete...
- This federal Project Grant award of $737,949 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to modernize clinical methods for assessing fluid excess and removal during in-center hemodialysis treatment. The long-term goal is to improve patient-centered outcomes by leveraging newer techniques like multi-frequency bioelectrical impedance spectroscopy...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $226,192 to Endonavis LLC to develop a novel over-the-scope platform for controlling variceal bleeding. The project aims to mate Endonavis' single-use endoscope technology with a novel balloon design to enable endoscopic visualization and active monitoring during placement for improved...
- This $203,676 federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to evaluate patient priorities and the impact of cost on surgical preference for the treatment of benign prostatic hyperplasia (BPH). The key objectives are to: 1) identify the perioperative factors most important to patients undergoing BPH surgical intervention;...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), through the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded a $324,678 Project Grant to Lumina Medical LLC, located in California, to develop an innovative Motorized Girth Adjustable Dilator. This medical device is designed to improve patient adherence to static-passive stretching treatment for anorectal disorders such as anismus and anal stenosis, which collectively affect...
- This Project Grant award of $356,032 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) supports the development of a novel bladder catheterization device. The project aims to create an innovative method for bladder drainage that addresses the significant morbidity and inconvenience associated with current catheterization approaches. Over 1 million Americans, including those with neurogenic bladder conditions, require catheter use for bladder drainage. The...
- This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $399,613 to Florida State University to develop a wearable device for prolonged penile oxygen saturation monitoring. The goal is to create a stretchable optical sensor that can contour to the skin of the penile shaft and measure changes in oxygen saturation, which may help...
- This federal Project Grant award of $117,000 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) will support research on the role of substance P and its receptor MRGPRX2 in the pathophysiology of irritable bowel syndrome (IBS). The Regents of the University of Michigan, through its Office of Research and Sponsored Projects, will conduct the research project from June 2025 to May 2027. The...
This federal Project Grant award for $234,000.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research), will support a clinical trial to evaluate the use of a novel point-of-care device (RED) to identify rectal evacuation disorders and guide pelvic floor physical therapy as a conservative treatment option for hemorrhoidal bleeding. The study will enroll 100 patients with hemorrhoidal bleeding and assess the validity of the point-of-care device compared to laboratory-based anorectal function tests, as well as evaluate the impact of this approach on global constipation and hemorrhoid symptoms. The award period runs from August 1, 2025 to July 31, 2027 and will be conducted by the Regents of the University of Michigan.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $234.0k | 8/1/25 |